JPMorgan Resumes Allscripts (MDRX) at Underweight

April 29, 2021 6:17 AM

JPMorgan analyst Anne Samuel resumes coverage on Allscripts (NASDAQ: MDRX) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found